Tag Archives: Martin Landry

GMP FirstEnergy Thinks BRP Inc’s Stock is Going to Recover

According to The Fly, gMP FirstEnergy analyst Martin Landry upgraded BRP Inc (DOOO – Research Report) to Buy yesterday. The company’s shares closed yesterday at $33.73, close to its 52-week low of $30.23. According to TipRanks.com, Landry is ranked #33

Cronos Group Inc (CRON) Receives a Buy from GMP FirstEnergy

On November 14, an analyst has provided a rating update for the Financial sector company, Cronos Group Inc (CRON – Research Report). GMP FirstEnergy’s analyst Martin Landry reiterates their Buy rating on the shares, with a C$14 price target. Landry

GMP FirstEnergy Keeps Their Buy Rating on Cronos Group Inc (CRON)

According to The Fly, in a report issued on November 14, Martin Landry from GMP FirstEnergy reiterated a Buy rating on Cronos Group Inc (CRON – Research Report). The company’s shares closed on Friday at $8.56. Landry has an average

GMP FirstEnergy Thinks Emblem Corp’s Stock is Going to Recover

Yesterday, an analyst has provided a rating update for the Healthcare company, Emblem Corp (TSXV: EMC). Analyst Martin Landry from GMP FirstEnergy rated Emblem Corp (TSXV: EMC) a Buy, setting a C$1.75 price target. According to TipRanks.com, Landry is ranked

GMP FirstEnergy Reiterates Their Hold Rating on Aimia Inc.

The Services sector company, Aimia Inc. (TSX: AIM), has received a rating update from a Wall Street analyst yesterday. GMP FirstEnergy’s analyst Martin Landry reiterates their Hold rating on the shares, with a C$4 price target. According to TipRanks.com, Landry

Cipher Pharma Gets a Buy Rating from GMP FirstEnergy

Wall Street analyst has provided a review for the Healthcare company today, but retained the same rating on the stock. GMP FirstEnergy’s analyst Martin Landry reiterates their Buy rating on the shares of Cipher Pharma (TSX: CPH), with a C$7